DrugPatentWatch Database Preview
Pharmtak Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for PHARMTAK INC, and what generic and branded alternatives to PHARMTAK INC drugs are available?
PHARMTAK INC has two approved drugs.
There are two tentative approvals on PHARMTAK INC drugs.
Summary for Pharmtak Inc
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Pharmtak Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmtak Inc | OLANZAPINE | olanzapine | TABLET;ORAL | 206924-005 | Dec 31, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Pharmtak Inc | OLANZAPINE | olanzapine | TABLET;ORAL | 206924-002 | Dec 31, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Pharmtak Inc | OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 206892-003 | Dec 31, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Pharmtak Inc | OLANZAPINE | olanzapine | TABLET;ORAL | 206924-004 | Dec 31, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
